Companies: 10,795·Total market cap: $144.5T
CG Oncology, Inc. Common stock

CG Oncology, Inc. Common stock

CGONNASDAQHealthcare● Active
$53.72
$-2.37(-4.23%)
Market Cap$4.7B
P/E Ratio
52W High$75.5
52W Low$23.65
Overview

CG Oncology, Inc. Common stock (CGON) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CGON · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-2.34cgon eps ttm · cgon earnings per shareEarnings history
PE Ratio (TTM)cgon pe ratio ttm · cgon price to earningsPE Ratio deep dive
Revenue (TTM)$5.1Mcgon revenue ttm · cgon annual revenueFull revenue history
Dividend YieldNo Dividenddoes cgon pay dividends · cgon dividend yieldDividend history
Shares Outstanding77.3Mcgon shares outstanding · cgon floatShares outstanding history
Next EarningsAug 7, 2026Est.cgon earnings date · cgon next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$4.0M▲ +254.70% YoY
202320242025
cg oncology, inc. common stock revenue · cgon revenue 2025
FY 2025Net Income-$161.0M▼ 82.87% YoY
202320242025
cg oncology, inc. common stock net income · cgon profit 2025
FY 2025EPS$-2.08▼ 47.52% YoY
202320242025
cgon eps · cg oncology, inc. common stock earnings per share 2025
TTM:Revenue: $5.1MNet Income: -$186.7MEPS: $-2.34View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy10 analystsis cgon a buy · cgon analyst rating
Strong Buy
0
Buy
10
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$70.00Low
$53.72Current
$82.57Avg Target53.70% upside
$93.00High
cgon price target · cgon 12 month forecast

Total: 10 · Buy rate: 100.0%

The CGON analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $82.57, representing +53.70% upside from the current price of $53.72.

Stock Performance

Full History
1D-4.23%
1W-2.93%
1M-22.84%
3M-13.19%
YTD+29.38%
1Y+98.96%
5Y+44.53%

About CG Oncology, Inc. Common stock

CEOArthur Kuan
IPO DateJan 25, 2024
Employees113
CountryUS

CG Oncology, Inc. Common stock CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their pro…

what is cg oncology, inc. common stock · cgon stock overview · cg oncology, inc. common stock company profile · who is cg oncology, inc. common stock ceo · cgon NASDAQ · cg oncology, inc. common stock headquarters · cg oncology, inc. common stock business segments

About Stock Overview & Key Data

CG Oncology, Inc. Common stock (CGON) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 25, 2024. As of the latest trading session, CGON stock price is $53.72, with a market capitalization of $4.7B. The stock has returned +98.96% over the past 12 months and +29.38% year-to-date.

According to 10 Wall Street analysts, the consensus rating for CG Oncology, Inc. Common stock stock is Buy, with an average 12-month price target of $82.57. In fiscal year 2025, CG Oncology, Inc. Common stock reported revenue of $4.0M and net income of -$161.0M. For detailed data — including CG Oncology, Inc. Common stock revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, CG Oncology, Inc. Common stock (CGON) stock price is $53.72. The stock is traded on NASDAQ under the ticker symbol CGON. The 52-week range is $23.65 – $75.50.

CGON stock priceCGON quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice